首页 > 最新文献

Multidisciplinary Respiratory Medicine最新文献

英文 中文
Diagnosis of amyotrophic lateral sclerosis by respiratory function test. 通过呼吸功能测试诊断肌萎缩侧索硬化症。
IF 2.3 Q3 RESPIRATORY SYSTEM Pub Date : 2023-12-27 eCollection Date: 2023-01-17 DOI: 10.4081/mrm.2023.941
Francesca Polverino, Simone Sampaolo, Antonio Capuozzo, Marco Fasolino, Michele Aliberti, Ersilia Satta, Carlo Santoriello, Mario Polverino

The diagnostic criterion for amyotrophic lateral sclerosis (ALS) based on the findings of concomitant clinical and electrophysiological evidence of upper and lower motor neuron involvement may remain unsatisfied for months and in some patients, even for years in the early stage of the disease. Since respiratory involvement is an onset symptom of ALS in only 1-3% of patients, pulmonary assessment has never been considered useful in the early diagnosis of ALS. However, studies on pulmonary function are lacking, especially in those early stages where neurologic tests are also inconclusive. In contrast to the scarcity of data in the early stages, as the disease progresses, it is increasingly enriched by a rich set of symptoms and positive respiratory tests until respiratory failure occurs, which represents the main cause of death in ALS. Hereby we analyze the main pulmonary function tests (PFT) in the various stages of the disease, up to the recent evidence for the possibility of an early diagnosis.

肌萎缩性脊髓侧索硬化症(ALS)的诊断标准是同时发现上下运动神经元受累的临床和电生理学证据,但这一标准可能数月都无法满足患者的要求,有些患者甚至在疾病早期数年都无法满足要求。由于只有 1-3% 的 ALS 患者会出现呼吸系统受累的症状,因此肺功能评估从未被认为对 ALS 的早期诊断有用。然而,有关肺功能的研究却很缺乏,尤其是在神经系统检查也没有结果的早期阶段。与早期阶段数据匮乏形成鲜明对比的是,随着病情的发展,患者会出现越来越多的症状,呼吸系统检查也呈阳性,直至出现呼吸衰竭,而呼吸衰竭是导致 ALS 死亡的主要原因。在此,我们分析了该疾病不同阶段的主要肺功能检查(PFT),以及最近关于早期诊断可能性的证据。
{"title":"Diagnosis of amyotrophic lateral sclerosis by respiratory function test.","authors":"Francesca Polverino, Simone Sampaolo, Antonio Capuozzo, Marco Fasolino, Michele Aliberti, Ersilia Satta, Carlo Santoriello, Mario Polverino","doi":"10.4081/mrm.2023.941","DOIUrl":"10.4081/mrm.2023.941","url":null,"abstract":"<p><p>The diagnostic criterion for amyotrophic lateral sclerosis (ALS) based on the findings of concomitant clinical and electrophysiological evidence of upper and lower motor neuron involvement may remain unsatisfied for months and in some patients, even for years in the early stage of the disease. Since respiratory involvement is an onset symptom of ALS in only 1-3% of patients, pulmonary assessment has never been considered useful in the early diagnosis of ALS. However, studies on pulmonary function are lacking, especially in those early stages where neurologic tests are also inconclusive. In contrast to the scarcity of data in the early stages, as the disease progresses, it is increasingly enriched by a rich set of symptoms and positive respiratory tests until respiratory failure occurs, which represents the main cause of death in ALS. Hereby we analyze the main pulmonary function tests (PFT) in the various stages of the disease, up to the recent evidence for the possibility of an early diagnosis.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"18 1","pages":"941"},"PeriodicalIF":2.3,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10782889/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139698907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving the management of patients with chronic cardiac and respiratory diseases by extending pulse-oximeter uses: the dynamic pulse-oximetry 通过扩大脉搏氧饱和度计的使用范围改善对慢性心脏病和呼吸系统疾病患者的管理:动态脉搏氧饱和度计
IF 2.3 Q3 RESPIRATORY SYSTEM Pub Date : 2023-12-20 DOI: 10.4081/mrm.2023.922
Stefano Nardini, Ulisse Corbanese, A. Visconti, Jacopo Dalle Mule, C. Sanguinetti, F. De Benedetto
Respiratory and cardio-vascular chronic diseases are among the most common noncommunicable diseases (NCDs) worldwide, accounting for a significant portion of health-care costs in terms of mortality and disability. Their prevalence is expected to rise further in the coming years as the population ages. The current model of care for diagnosing and monitoring NCDs is out of date because it results in late medical interventions and/or an unfavourable cost-effectiveness balance based on reported symptoms and subsequent inpatient tests and treatments. Health projects and programs are being implemented in an attempt to move the time of an NCD's diagnosis, as well as its monitoring and follow-up, out of hospital settings and as close to real life as possible, with the goal of benefiting both patients' quality of life and health system budgets. Following the SARS-CoV-2 pandemic, this implementation received additional impetus. Pulse-oximeters (POs) are currently used in a variety of clinical settings, but they can also aid in the telemonitoring of certain patients. POs that can measure activities as well as pulse rate and oxygen saturation as proxies of cardio-vascular and respiratory function are now being introduced to the market. To obtain these data, the devices must be absolutely reliable, that is, accurate and precise, and capable of recording for a long enough period of time to allow for diagnosis. This paper is a review of current pulse-oximetry (POy) use, with the goal of investigating how its current use can be expanded to manage not only cardio-respiratory NCDs, but also acute emergencies with telemonitoring when hospitalization is not required but the patients' situation is uncertain. Newly designed devices, both "consumer" and "professional," will be scrutinized, particularly those capable of continuously recording vital parameters on a 24-hour basis and coupling them with daily activities, a practice known as dynamic pulse-oximetry.
呼吸系统和心血管慢性疾病是全球最常见的非传染性疾病(NCDs)之一,在死亡率和残疾率方面占医疗成本的很大一部分。随着人口老龄化的加剧,预计这些疾病的发病率在未来几年还会进一步上升。目前诊断和监测非传染性疾病的医疗模式已经过时,因为这种模式会导致医疗干预过晚和/或基于报告的症状和随后的住院检查和治疗而产生不利的成本效益平衡。目前正在实施的卫生项目和计划试图将非传染性疾病的诊断、监测和随访时间从医院环境中移出,并尽可能地贴近实际生活,目的是提高患者的生活质量并增加卫生系统的预算。在 SARS-CoV-2 大流行之后,这项工作得到了更多的推动。脉搏氧饱和度计(PO)目前被广泛应用于各种临床环境中,但它们也可以帮助对某些病人进行远程监控。脉搏血氧仪可以测量活动量以及脉搏和血氧饱和度,是心血管和呼吸功能的代用指标,目前已被引入市场。要获得这些数据,设备必须绝对可靠,即准确、精确,并能记录足够长的时间,以便进行诊断。本文回顾了脉搏氧饱和度(POy)的当前使用情况,目的是研究如何扩大其当前的使用范围,以便不仅管理心肺功能非传染性疾病,而且在不需要住院但患者情况不确定的情况下,通过远程监控管理急性急症。将对新设计的 "消费者 "和 "专业 "设备进行仔细研究,特别是那些能够 24 小时连续记录生命参数并将其与日常活动相结合的设备,这种做法被称为动态脉搏-氧饱和度测量法。
{"title":"Improving the management of patients with chronic cardiac and respiratory diseases by extending pulse-oximeter uses: the dynamic pulse-oximetry","authors":"Stefano Nardini, Ulisse Corbanese, A. Visconti, Jacopo Dalle Mule, C. Sanguinetti, F. De Benedetto","doi":"10.4081/mrm.2023.922","DOIUrl":"https://doi.org/10.4081/mrm.2023.922","url":null,"abstract":"Respiratory and cardio-vascular chronic diseases are among the most common noncommunicable diseases (NCDs) worldwide, accounting for a significant portion of health-care costs in terms of mortality and disability. Their prevalence is expected to rise further in the coming years as the population ages. The current model of care for diagnosing and monitoring NCDs is out of date because it results in late medical interventions and/or an unfavourable cost-effectiveness balance based on reported symptoms and subsequent inpatient tests and treatments. Health projects and programs are being implemented in an attempt to move the time of an NCD's diagnosis, as well as its monitoring and follow-up, out of hospital settings and as close to real life as possible, with the goal of benefiting both patients' quality of life and health system budgets. Following the SARS-CoV-2 pandemic, this implementation received additional impetus. Pulse-oximeters (POs) are currently used in a variety of clinical settings, but they can also aid in the telemonitoring of certain patients. POs that can measure activities as well as pulse rate and oxygen saturation as proxies of cardio-vascular and respiratory function are now being introduced to the market. To obtain these data, the devices must be absolutely reliable, that is, accurate and precise, and capable of recording for a long enough period of time to allow for diagnosis. This paper is a review of current pulse-oximetry (POy) use, with the goal of investigating how its current use can be expanded to manage not only cardio-respiratory NCDs, but also acute emergencies with telemonitoring when hospitalization is not required but the patients' situation is uncertain. Newly designed devices, both \"consumer\" and \"professional,\" will be scrutinized, particularly those capable of continuously recording vital parameters on a 24-hour basis and coupling them with daily activities, a practice known as dynamic pulse-oximetry.","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"39 24","pages":""},"PeriodicalIF":2.3,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138955852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Local allergic rhinitis: considerations 局部过敏性鼻炎:注意事项
IF 2.3 Q3 RESPIRATORY SYSTEM Pub Date : 2023-12-19 DOI: 10.4081/mrm.2023.939
L. Bellussi, Francesco Maria Passali, Desiderio Passali
The term "local allergic rhinitis" has gained popularity as a clinical entity in recent years. Despite the apparent contradiction in the definitions of "nasal" and "local," we offer insights based on our extensive experience in the field. Local allergic rhinitis has been recognized and treated for many years, so it is not a new discovery. The nasal provocation test, which was introduced in the 1980s, was critical in identifying allergic rhinitis cases with suggestive symptoms but negative allergy tests. Our reflections aim to contribute to a precise terminological decision that is consistent with various points of view.
近年来,"局部过敏性鼻炎 "作为一个临床实体逐渐流行起来。尽管 "鼻腔 "和 "局部 "的定义明显存在矛盾,但我们还是根据自己在这一领域的丰富经验提出了自己的见解。局部过敏性鼻炎已被认识和治疗多年,因此并非新发现。20 世纪 80 年代引入的鼻激发试验对于识别有提示症状但过敏试验阴性的过敏性鼻炎病例至关重要。我们的思考旨在为准确的术语决定做出贡献,并与各种观点保持一致。
{"title":"Local allergic rhinitis: considerations","authors":"L. Bellussi, Francesco Maria Passali, Desiderio Passali","doi":"10.4081/mrm.2023.939","DOIUrl":"https://doi.org/10.4081/mrm.2023.939","url":null,"abstract":"The term \"local allergic rhinitis\" has gained popularity as a clinical entity in recent years. Despite the apparent contradiction in the definitions of \"nasal\" and \"local,\" we offer insights based on our extensive experience in the field. Local allergic rhinitis has been recognized and treated for many years, so it is not a new discovery. The nasal provocation test, which was introduced in the 1980s, was critical in identifying allergic rhinitis cases with suggestive symptoms but negative allergy tests. Our reflections aim to contribute to a precise terminological decision that is consistent with various points of view.","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"112 10","pages":""},"PeriodicalIF":2.3,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138959569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The study of trends in mortality of respiratory system cancers in Babol, North of Iran (2013-2021) 伊朗北部巴博勒呼吸系统癌症死亡率趋势研究(2013-2021 年)
IF 2.3 Q3 RESPIRATORY SYSTEM Pub Date : 2023-12-18 DOI: 10.4081/mrm.2023.929
Seyed-Hossein Hosseini-Berneti, Mohsen Karami, Fatemeh Bayani, Mehdi Moghaddasi, Ozra Babazade, Pouyan Ebrahimi, Hossein-Ali Nikbakht
Background: In Iran, cancers are known as the second leading cause of death, among which respiratory system cancers are particularly important because lung cancer is the second most common cause of death in this country. This study aimed to estimate the crude and age-standardized mortality and its trends during 9 years in the northern city of Iran, Babol.Methods: In this cross-sectional study, all the recorded deaths due to respiratory system cancers in Babol during the years 2013-2021 on the Classification of Causes of Deaths and Death Registration System of Babol University of Medical Sciences were taken into consideration, and the population estimate was based on the latest census. Finally, the crude and age-standardized rates of mortality and trends of cancer incidents were calculated.Results: In general, 393 deaths with an overall mean age of 67.8±3.9 years have happened due to respiratory system cancers. The crude and standardized rates of respiratory system cancers increased from 6.5 and 5.5 per hundred thousand people in 2013 to 9.1 and 7.8 per hundred thousand people in 2021, respectively. With each decade in age, their trends increased significantly in men (p=0.024) and remained constant in women (p=0.262). In examining the trend of respiratory system cancers, we found an increasing trend for lung cancer and a constant trend for larynx and oropharynx cancers. There was also a decreasing trend for hypopharyngeal cancer.Conclusions: The age-standardized rate and trend of respiratory system cancers are increasing. Therefore, it is important to prevent their prevalence by reducing the risk factors and increasing the general awareness of risks and timely diagnosis.
背景:在伊朗,癌症被称为第二大死因,其中呼吸系统癌症尤为重要,因为肺癌是该国第二大常见死因。本研究旨在估算伊朗北部城市巴博勒 9 年间的粗死亡率和年龄标准化死亡率及其趋势:在这项横断面研究中,根据巴博勒医科大学的死亡原因分类和死亡登记系统,考虑了巴博勒在 2013-2021 年期间因呼吸系统癌症死亡的所有记录,并根据最新的人口普查估计了人口数量。最后,计算了粗死亡率和年龄标准化死亡率以及癌症发病趋势:总体而言,共有 393 人死于呼吸系统癌症,平均年龄(67.8±3.9)岁。呼吸系统癌症的粗死亡率和标准化死亡率分别从 2013 年的每十万人 6.5 例和 5.5 例上升到 2021 年的每十万人 9.1 例和 7.8 例。随着年龄每增加 10 岁,男性的趋势显著增加(p=0.024),而女性则保持不变(p=0.262)。在研究呼吸系统癌症的趋势时,我们发现肺癌呈上升趋势,喉癌和口咽癌的趋势保持不变。下咽癌也呈下降趋势:结论:呼吸系统癌症的年龄标准化发病率和发病趋势均呈上升趋势。结论:呼吸系统癌症的年龄标准化发病率和发病趋势均呈上升趋势,因此,通过减少危险因素、提高公众的风险意识和及时诊断来预防呼吸系统癌症的流行非常重要。
{"title":"The study of trends in mortality of respiratory system cancers in Babol, North of Iran (2013-2021)","authors":"Seyed-Hossein Hosseini-Berneti, Mohsen Karami, Fatemeh Bayani, Mehdi Moghaddasi, Ozra Babazade, Pouyan Ebrahimi, Hossein-Ali Nikbakht","doi":"10.4081/mrm.2023.929","DOIUrl":"https://doi.org/10.4081/mrm.2023.929","url":null,"abstract":"Background: In Iran, cancers are known as the second leading cause of death, among which respiratory system cancers are particularly important because lung cancer is the second most common cause of death in this country. This study aimed to estimate the crude and age-standardized mortality and its trends during 9 years in the northern city of Iran, Babol.Methods: In this cross-sectional study, all the recorded deaths due to respiratory system cancers in Babol during the years 2013-2021 on the Classification of Causes of Deaths and Death Registration System of Babol University of Medical Sciences were taken into consideration, and the population estimate was based on the latest census. Finally, the crude and age-standardized rates of mortality and trends of cancer incidents were calculated.Results: In general, 393 deaths with an overall mean age of 67.8±3.9 years have happened due to respiratory system cancers. The crude and standardized rates of respiratory system cancers increased from 6.5 and 5.5 per hundred thousand people in 2013 to 9.1 and 7.8 per hundred thousand people in 2021, respectively. With each decade in age, their trends increased significantly in men (p=0.024) and remained constant in women (p=0.262). In examining the trend of respiratory system cancers, we found an increasing trend for lung cancer and a constant trend for larynx and oropharynx cancers. There was also a decreasing trend for hypopharyngeal cancer.Conclusions: The age-standardized rate and trend of respiratory system cancers are increasing. Therefore, it is important to prevent their prevalence by reducing the risk factors and increasing the general awareness of risks and timely diagnosis.","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":" 12","pages":""},"PeriodicalIF":2.3,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138995298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rehabilitation complexity scale and reimbursement of in-hospital pulmonary rehabilitation. 康复复杂程度表和院内肺康复的报销。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2023-11-30 eCollection Date: 2023-01-17 DOI: 10.4081/mrm.2023.936
Michele Vitacca, Mara Paneroni, Nicolino Ambrosino

Background: The use of case-based reimbursement for medical rehabilitation is greatly discussed. The investigators explored the relationship between disability and reimbursement opportunities in individuals with respiratory diseases undergoing in-hospital pulmonary rehabilitation (PR), considering the correlation (if any) between the Rehabilitation Complexity Scale (RCS-E v13) scores used at admission and the actual reimbursement.

Methods: This study is part of a larger prospective multicenter study conducted by eight Pulmonary Rehabilitation Units in Italy. Here, investigators considered only data from the Lombardy Region. On January 30th or February 28th, 2023, participants were allocated according to the main DRG into 4 groups [tracheostomized/ventilated (TX/V), chronic respiratory failure (CRF), COPD, and miscellaneous group]. We recorded anthropometrics, diagnosis, international outcome measures, and calculated admission and discharge RCS-E v13 scores and hospital stay reimbursement according to the healthcare system (HS).

Results: Three hundred and sixteen participants were evaluated. Patients were elderly, in the majority of cases with CRF, presenting comorbidities, disability, dyspnea, and reduced effort tolerance. At admission, RCS-E v13 showed an average moderate value of complexity. The median (IQR) HS reimbursement/stay was different among groups. RCSE v13 evaluated at admission was weakly (r=0.3471), but significantly related to the HS reimbursement/stay (p<0.0001) mainly due to TX/V and miscellaneous subgroups, while no relationship was found for COPD and CRF patients. After PR, all outcome measures improved significantly in all groups (p<0.001 for all). Higher RCS-E v13 scores at admission did not correspond to a proper amount of reimbursement, being this latter under- or over-estimated if compared to needs assessed by RCS-E v13. RCS-E v13 at discharge decreased for all subgroups (range from -6 to -11) reaching a low value of complexity.

Conclusions: The RCS-E v13 disability score does not fully mirror the HS reimbursement for patients undergoing inhospital PR.

背景:在医疗康复中使用基于病例的报销方式引起了广泛讨论。研究人员探讨了接受院内肺康复(PR)的呼吸系统疾病患者的残疾情况与报销机会之间的关系,并考虑了入院时使用的康复复杂性量表(RCS-E v13)评分与实际报销之间的相关性(如果有的话):本研究是意大利八家肺康复机构开展的大型前瞻性多中心研究的一部分。在此,研究人员只考虑了伦巴第大区的数据。在 2023 年 1 月 30 日或 2 月 28 日,研究人员根据主要 DRG 将参与者分为 4 组[气管插管/通气组(TX/V)、慢性呼吸衰竭组(CRF)、慢性阻塞性肺疾病组和其他组]。我们记录了人体测量、诊断和国际结果测量,并根据医疗系统(HS)计算了入院和出院时的 RCS-E v13 评分和住院报销费用:对 316 名参与者进行了评估。患者均为老年人,大多数患有慢性阻塞性肺疾病,有合并症、残疾、呼吸困难和耐受力下降。入院时,RCS-E v13 平均显示为中度复杂值。各组的 HS 报销/住院时间中位数(IQR)不同。入院时评估的 RCS-E v13 与 HS 报销/住院时间呈弱相关(r=0.3471),但有显著相关性(p结论:RCS-E v13 残疾评分并不完全反映住院 PR 患者的 HS 报销情况。
{"title":"Rehabilitation complexity scale and reimbursement of in-hospital pulmonary rehabilitation.","authors":"Michele Vitacca, Mara Paneroni, Nicolino Ambrosino","doi":"10.4081/mrm.2023.936","DOIUrl":"10.4081/mrm.2023.936","url":null,"abstract":"<p><strong>Background: </strong>The use of case-based reimbursement for medical rehabilitation is greatly discussed. The investigators explored the relationship between disability and reimbursement opportunities in individuals with respiratory diseases undergoing in-hospital pulmonary rehabilitation (PR), considering the correlation (if any) between the Rehabilitation Complexity Scale (RCS-E v13) scores used at admission and the actual reimbursement.</p><p><strong>Methods: </strong>This study is part of a larger prospective multicenter study conducted by eight Pulmonary Rehabilitation Units in Italy. Here, investigators considered only data from the Lombardy Region. On January 30<sup>th</sup> or February 28<sup>th</sup>, 2023, participants were allocated according to the main DRG into 4 groups [tracheostomized/ventilated (TX/V), chronic respiratory failure (CRF), COPD, and miscellaneous group]. We recorded anthropometrics, diagnosis, international outcome measures, and calculated admission and discharge RCS-E v13 scores and hospital stay reimbursement according to the healthcare system (HS).</p><p><strong>Results: </strong>Three hundred and sixteen participants were evaluated. Patients were elderly, in the majority of cases with CRF, presenting comorbidities, disability, dyspnea, and reduced effort tolerance. At admission, RCS-E v13 showed an average moderate value of complexity. The median (IQR) HS reimbursement/stay was different among groups. RCSE v13 evaluated at admission was weakly (r=0.3471), but significantly related to the HS reimbursement/stay (p<0.0001) mainly due to TX/V and miscellaneous subgroups, while no relationship was found for COPD and CRF patients. After PR, all outcome measures improved significantly in all groups (p<0.001 for all). Higher RCS-E v13 scores at admission did not correspond to a proper amount of reimbursement, being this latter under- or over-estimated if compared to needs assessed by RCS-E v13. RCS-E v13 at discharge decreased for all subgroups (range from -6 to -11) reaching a low value of complexity.</p><p><strong>Conclusions: </strong>The RCS-E v13 disability score does not fully mirror the HS reimbursement for patients undergoing inhospital PR.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"18 1","pages":"936"},"PeriodicalIF":2.0,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10726991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139059053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression of HIF-1α in pediatric asthmatic patients. 儿科哮喘患者体内 HIF-1α 的表达。
IF 2.3 Q3 RESPIRATORY SYSTEM Pub Date : 2023-11-23 eCollection Date: 2023-01-17 DOI: 10.4081/mrm.2023.927
Víctor Gonzalez-Uribe, Ricardo Martinez-Tenopala, Alejandra Osorio-Martínez, Jimena Prieto-Gomez, Agustin Lammoglia Kirsch, Christian R Alcocer-Arreguin, Zaira Selene Mojica-Gonzalez

Background: Several studies have suggested that HIF-1α regulates eosinophil activity and induces epithelial inflammation via NF-κB activation in the pathophysiology of asthma. The purpose of this study was to examine the expression of the transcription factors HIF-1α and nuclear HIF in mononuclear cells obtained from peripheral blood samples of healthy pediatric patients, asthmatic patients, and asthmatic exacerbations, regardless of disease severity.

Methods: HIF-1 levels were measured using immunocytochemistry in 133 patients aged 6 to 17 years in this crosssectional and comparative study. A microscope was used to examine glass slides, and positive cells were counted in four fields per slide using an image analyzer.

Results: HIF-1α and nuclear HIF levels were significantly higher in asthma patients and even higher in patients experiencing asthma attacks (p<0.0001, 95% CI). There was no significant difference in the percentage of HIF-1α expression between groups with intermittent asthma and those with mild persistent asthma, nor between patients with asthma and those experiencing asthma exacerbations.

Conclusions: When compared to healthy individuals, the expression of nuclear HIF and HIF-1α is increased in peripheral mononuclear cells in asthma patients and even more so in asthma exacerbations. This suggests that HIF-1α is important in the pathogenesis of this disease.

背景:多项研究表明,在哮喘的病理生理学中,HIF-1α通过激活NF-κB调节嗜酸性粒细胞的活性并诱导上皮炎症。本研究的目的是检测健康儿科患者、哮喘患者和哮喘加重患者(无论疾病严重程度如何)外周血样本单核细胞中转录因子 HIF-1α 和核 HIF 的表达情况。使用显微镜检查玻璃载玻片,并使用图像分析仪对每张载玻片的四个视野中的阳性细胞进行计数:结果:哮喘患者的 HIF-1α 和核 HIF 水平明显升高,哮喘发作患者的 HIF-1α 和核 HIF 水平甚至更高(p 结论:与健康人相比,哮喘患者的 HIF-1α 和核 HIF 水平明显升高:与健康人相比,哮喘患者外周单核细胞中核 HIF 和 HIF-1α 的表达量增加,在哮喘发作时更是如此。这表明,HIF-1α 在该疾病的发病机制中起着重要作用。
{"title":"Expression of HIF-1α in pediatric asthmatic patients.","authors":"Víctor Gonzalez-Uribe, Ricardo Martinez-Tenopala, Alejandra Osorio-Martínez, Jimena Prieto-Gomez, Agustin Lammoglia Kirsch, Christian R Alcocer-Arreguin, Zaira Selene Mojica-Gonzalez","doi":"10.4081/mrm.2023.927","DOIUrl":"10.4081/mrm.2023.927","url":null,"abstract":"<p><strong>Background: </strong>Several studies have suggested that HIF-1α regulates eosinophil activity and induces epithelial inflammation <i>via</i> NF-κB activation in the pathophysiology of asthma. The purpose of this study was to examine the expression of the transcription factors HIF-1α and nuclear HIF in mononuclear cells obtained from peripheral blood samples of healthy pediatric patients, asthmatic patients, and asthmatic exacerbations, regardless of disease severity.</p><p><strong>Methods: </strong>HIF-1 levels were measured using immunocytochemistry in 133 patients aged 6 to 17 years in this crosssectional and comparative study. A microscope was used to examine glass slides, and positive cells were counted in four fields per slide using an image analyzer.</p><p><strong>Results: </strong>HIF-1α and nuclear HIF levels were significantly higher in asthma patients and even higher in patients experiencing asthma attacks (p<0.0001, 95% CI). There was no significant difference in the percentage of HIF-1α expression between groups with intermittent asthma and those with mild persistent asthma, nor between patients with asthma and those experiencing asthma exacerbations.</p><p><strong>Conclusions: </strong>When compared to healthy individuals, the expression of nuclear HIF and HIF-1α is increased in peripheral mononuclear cells in asthma patients and even more so in asthma exacerbations. This suggests that HIF-1α is important in the pathogenesis of this disease.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"18 1","pages":"927"},"PeriodicalIF":2.3,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10715186/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139059052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes comparison between the first and the subsequent SARS-CoV-2 waves – a systematic review and meta-analysis 第一波和随后的SARS-CoV-2波的结果比较——系统回顾和荟萃分析
Q3 RESPIRATORY SYSTEM Pub Date : 2023-11-02 DOI: 10.4081/mrm.2023.933
Tulio Caldonazo, Ricardo E. Treml, Felipe S.L. Vianna, Panagiotis Tasoudis, Hristo Kirov, Murat Mukharyamov, Torsten Doenst, João M. Silva Jr
Background: In the beginning of the SARS-CoV-2 pandemic, health care professionals dealing with COVID-19 had to rely exclusively on general supportive measures since specific treatments were unknown. The subsequent waves could be faced with new diagnostic and therapeutic tools (e.g., anti-viral medications and vaccines). We performed a meta-analysis and systematic review to compare clinical endpoints between the first and subsequent waves. Methods: Three databases were assessed. The primary outcome was in-hospital mortality. The secondary outcomes were intensive care unit (ICU) mortality, ICU length of stay (LOS), acute renal failure, extracorporeal membrane oxygenation (ECMO) implantation, mechanical ventilation time, hospital LOS, systemic thromboembolism, myocarditis and ventilator associated pneumonia. Results: A total of 25 studies with 126,153 patients were included. There was no significant difference for the primary endpoint (OR=0.94, 95% CI 0.83-1.07, p=0.35). The first wave group presented higher rates of ICU LOS (SMD= 0.23, 95% CI 0.11-0.35, p<0.01), acute renal failure (OR=1.71, 95% CI 1.36-2.15, p<0.01) and ECMO implantation (OR=1.64, 95% CI 1.06-2.52, p=0.03). The other endpoints did not show significant differences.Conclusions: The analysis suggests that the first wave group, when compared with the subsequent waves group, presented higher rates of ICU LOS, acute renal failure and ECMO implantation, without significant difference in in-hospital or ICU mortality, mechanical ventilation time, hospital LOS, systemic thromboembolism, myocarditis or ventilator-associated pneumonia.
背景:在SARS-CoV-2大流行初期,由于具体治疗方法尚不清楚,卫生保健专业人员处理COVID-19时只能依靠一般的支持措施。随后的浪潮可能面临新的诊断和治疗工具(例如抗病毒药物和疫苗)。我们进行了荟萃分析和系统回顾,比较了第一波和随后两波的临床终点。方法:对三个数据库进行评估。主要终点是住院死亡率。次要结局为重症监护病房(ICU)死亡率、ICU住院时间(LOS)、急性肾功能衰竭、体外膜氧合(ECMO)植入、机械通气时间、医院LOS、全身血栓栓塞、心肌炎和呼吸机相关性肺炎。结果:共纳入25项研究,126153例患者。主要终点无显著差异(OR=0.94, 95% CI 0.83-1.07, p=0.35)。第一波组ICU LOS (SMD= 0.23, 95% CI 0.11-0.35, p= 0.01)、急性肾功能衰竭(OR=1.71, 95% CI 1.36-2.15, p= 0.01)和ECMO植入(OR=1.64, 95% CI 1.06-2.52, p=0.03)发生率较高。其他终点无显著性差异。结论:分析提示,与后续波组相比,第一波组ICU LOS、急性肾功能衰竭和ECMO植入的发生率更高,在院内或ICU死亡率、机械通气时间、院内LOS、全身性血栓栓塞、心肌炎或呼吸机相关性肺炎方面无显著差异。
{"title":"Outcomes comparison between the first and the subsequent SARS-CoV-2 waves – a systematic review and meta-analysis","authors":"Tulio Caldonazo, Ricardo E. Treml, Felipe S.L. Vianna, Panagiotis Tasoudis, Hristo Kirov, Murat Mukharyamov, Torsten Doenst, João M. Silva Jr","doi":"10.4081/mrm.2023.933","DOIUrl":"https://doi.org/10.4081/mrm.2023.933","url":null,"abstract":"Background: In the beginning of the SARS-CoV-2 pandemic, health care professionals dealing with COVID-19 had to rely exclusively on general supportive measures since specific treatments were unknown. The subsequent waves could be faced with new diagnostic and therapeutic tools (e.g., anti-viral medications and vaccines). We performed a meta-analysis and systematic review to compare clinical endpoints between the first and subsequent waves. Methods: Three databases were assessed. The primary outcome was in-hospital mortality. The secondary outcomes were intensive care unit (ICU) mortality, ICU length of stay (LOS), acute renal failure, extracorporeal membrane oxygenation (ECMO) implantation, mechanical ventilation time, hospital LOS, systemic thromboembolism, myocarditis and ventilator associated pneumonia. Results: A total of 25 studies with 126,153 patients were included. There was no significant difference for the primary endpoint (OR=0.94, 95% CI 0.83-1.07, p=0.35). The first wave group presented higher rates of ICU LOS (SMD= 0.23, 95% CI 0.11-0.35, p<0.01), acute renal failure (OR=1.71, 95% CI 1.36-2.15, p<0.01) and ECMO implantation (OR=1.64, 95% CI 1.06-2.52, p=0.03). The other endpoints did not show significant differences.Conclusions: The analysis suggests that the first wave group, when compared with the subsequent waves group, presented higher rates of ICU LOS, acute renal failure and ECMO implantation, without significant difference in in-hospital or ICU mortality, mechanical ventilation time, hospital LOS, systemic thromboembolism, myocarditis or ventilator-associated pneumonia.","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135936139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidisciplinary treatment of thoracic fistulous empyema caused by pulmonary infection: a retrospective study 肺部感染所致胸腔瘘性脓肿的多学科治疗回顾性研究
Q3 RESPIRATORY SYSTEM Pub Date : 2023-10-13 DOI: 10.4081/mrm.2023.926
Yasoo Sugiura, Hiroyuki Fujimoto, Toshinori Hashizume
Background: In cases of thoracic empyema, the presence of a fistula is known to be difficult to treat and associated with a poor prognosis. Few reports have described the management of fistulous empyema caused by lung parenchymal infection. The aim of this study was to describe the outcomes of multidisciplinary management of fistulous empyema caused by pneumonia or lung abscess due to common bacteria and mycobacteria.Methods: Among 108 cases of empyema surgically treated at Kanagawa Hospital over a 10-year period, 14 patients with fistulous empyema due to common bacteria (CBFE) or fistulous empyema due to mycobacteria (MFE) were analyzed. Fistulous empyema due to pneumonectomy was excluded.Results: Eight of the 9 patients with CBFE and 4 of the 5 patients with MFE were male. Patients with CBFE were more likely to be >65 years of age (p=0.052) and to have a poor performance status (p=0.078). The time from onset to first surgical treatment was significantly longer in MFE (median, 5 months; p=0.004). Five patients with CBFE and two patients with MFE underwent open window thoracostomy, while three patients with CBFE and four patients with MFE underwent endobronchial occlusion. Six patients (66%) with CBFE and 3 patients (60%) with MFE achieved fistula closure. Of the patients who underwent EBO, fistula closure was achieved in 3 (100%) of the patients with CBFE and in 2 (50%) of the patients with MFE. Fistula closure was not achieved in any case with non-tuberculous mycobacteria.Conclusions: Fistulous empyema caused by common bacteria or Mycobacterium tuberculosis could be cured by surgical treatment and endobronchial intervention with adequate antimicrobial therapy, but fistulous empyema caused by non-tuberculous mycobacteria proved to be intractable. The challenge in the treatment of fistulous empyema due to non-tuberculous mycobacteria is the achievement of bacterial negativity.
背景:在胸脓胸的病例中,瘘管的存在是很难治疗的,并且与预后不良有关。很少有关于肺实质感染引起的瘘管性脓肿处理的报道。本研究的目的是描述由常见细菌和分枝杆菌引起的肺炎或肺脓肿引起的瘘性脓肿的多学科治疗的结果。方法:分析神奈川县医院10年来收治的108例脓肿,其中14例为普通菌性(CBFE)和分枝杆菌性(MFE)造瘘性脓肿。排除肺切除术引起的瘘管性脓胸。结果:9例CBFE患者中8例为男性,5例MFE患者中4例为男性。CBFE患者年龄≥65岁(p=0.052),表现状态较差(p=0.078)。MFE患者从发病到第一次手术治疗的时间明显更长(中位,5个月;p = 0.004)。5例CBFE患者和2例MFE患者行开窗开胸术,3例CBFE患者和4例MFE患者行支气管内闭塞术。6例(66%)CBFE患者和3例(60%)MFE患者实现了瘘管闭合。在接受EBO治疗的患者中,3例(100%)CBFE患者和2例(50%)MFE患者的瘘管闭合成功。没有一例非结核分枝杆菌的瘘管闭合。结论:由普通细菌或结核分枝杆菌引起的瘘管性脓肿可通过手术治疗和支气管内干预治疗,并给予适当的抗菌药物治疗,但由非结核分枝杆菌引起的瘘管性脓肿是难以治愈的。非结核分枝杆菌引起的瘘管性脓肿治疗的挑战是实现细菌阴性。
{"title":"Multidisciplinary treatment of thoracic fistulous empyema caused by pulmonary infection: a retrospective study","authors":"Yasoo Sugiura, Hiroyuki Fujimoto, Toshinori Hashizume","doi":"10.4081/mrm.2023.926","DOIUrl":"https://doi.org/10.4081/mrm.2023.926","url":null,"abstract":"Background: In cases of thoracic empyema, the presence of a fistula is known to be difficult to treat and associated with a poor prognosis. Few reports have described the management of fistulous empyema caused by lung parenchymal infection. The aim of this study was to describe the outcomes of multidisciplinary management of fistulous empyema caused by pneumonia or lung abscess due to common bacteria and mycobacteria.Methods: Among 108 cases of empyema surgically treated at Kanagawa Hospital over a 10-year period, 14 patients with fistulous empyema due to common bacteria (CBFE) or fistulous empyema due to mycobacteria (MFE) were analyzed. Fistulous empyema due to pneumonectomy was excluded.Results: Eight of the 9 patients with CBFE and 4 of the 5 patients with MFE were male. Patients with CBFE were more likely to be &gt;65 years of age (p=0.052) and to have a poor performance status (p=0.078). The time from onset to first surgical treatment was significantly longer in MFE (median, 5 months; p=0.004). Five patients with CBFE and two patients with MFE underwent open window thoracostomy, while three patients with CBFE and four patients with MFE underwent endobronchial occlusion. Six patients (66%) with CBFE and 3 patients (60%) with MFE achieved fistula closure. Of the patients who underwent EBO, fistula closure was achieved in 3 (100%) of the patients with CBFE and in 2 (50%) of the patients with MFE. Fistula closure was not achieved in any case with non-tuberculous mycobacteria.Conclusions: Fistulous empyema caused by common bacteria or Mycobacterium tuberculosis could be cured by surgical treatment and endobronchial intervention with adequate antimicrobial therapy, but fistulous empyema caused by non-tuberculous mycobacteria proved to be intractable. The challenge in the treatment of fistulous empyema due to non-tuberculous mycobacteria is the achievement of bacterial negativity.","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"42 2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135853688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experimental studies and mathematical modeling of the viscoelastic rheology of tracheobronchial mucus from respiratory healthy patients. 呼吸系统健康患者气管支气管粘液粘弹性流变学的实验研究和数学模型。
IF 2.3 Q3 RESPIRATORY SYSTEM Pub Date : 2023-10-02 eCollection Date: 2023-01-17 DOI: 10.4081/mrm.2023.923
Sandra Melina Tauwald, Johanna Michel, Marie Brandt, Veronika Vielsmeier, Christian Stemmer, Lars Krenkel

Background: Tracheobronchial mucus plays a crucial role in pulmonary function by providing protection against inhaled pathogens. Due to its composition of water, mucins, and other biomolecules, it has a complex viscoelastic rheological behavior. This interplay of both viscous and elastic properties has not been fully described yet. In this study, we characterize the rheology of human mucus using oscillatory and transient tests. Based on the transient tests, we describe the material behavior of mucus under stress and strain loading by mathematical models.

Methods: Mucus samples were collected from clinically used endotracheal tubes. For rheological characterization, oscillatory amplitude-sweep and frequency-sweep tests, and transient creep-recovery and stress-relaxation tests were performed. The results of the transient test were approximated using the Burgers model, the Weibull distribution, and the six-element Maxwell model. The three-dimensional microstructure of the tracheobronchial mucus was visualized using scanning electron microscope imaging.

Results: Amplitude-sweep tests showed storage moduli ranging from 0.1 Pa to 10,000 Pa and a median critical strain of 4%. In frequency-sweep tests, storage and loss moduli increased with frequency, with the median of the storage modulus ranging from 10 Pa to 30 Pa, and the median of the loss modulus from 5 Pa to 14 Pa. The Burgers model approximates the viscoelastic behavior of tracheobronchial mucus during a constant load of stress appropriately (R2 of 0.99), and the Weibull distribution is suitable to predict the recovery of the sample after the removal of this stress (R2 of 0.99). The approximation of the stress-relaxation test data by a six-element Maxwell model shows a larger fit error (R2 of 0.91).

Conclusions: This study provides a detailed description of all process steps of characterizing the rheology of tracheobronchial mucus, including sample collection, microstructure visualization, and rheological investigation. Based on this characterization, we provide mathematical models of the rheological behavior of tracheobronchial mucus. These can now be used to simulate mucus flow in the respiratory system through numerical approaches.

背景:气管支气管粘液通过提供对吸入病原体的保护,在肺功能中发挥着至关重要的作用。由于其由水、粘蛋白和其他生物分子组成,它具有复杂的粘弹性流变行为。粘性和弹性特性的这种相互作用尚未得到充分描述。在这项研究中,我们使用振荡和瞬态测试来表征人类粘液的流变学。在瞬态试验的基础上,我们通过数学模型描述了粘液在应力和应变载荷下的材料行为。方法:从临床使用的气管插管中采集粘液样品。对于流变特性,进行了振荡振幅扫描和频率扫描试验,以及瞬态蠕变恢复和应力松弛试验。瞬态试验的结果使用Burgers模型、威布尔分布和六元Maxwell模型进行近似。气管支气管粘液的三维微观结构通过扫描电子显微镜成像进行可视化。结果:振幅扫描测试显示储能模量在0.1Pa至10000Pa之间,中值临界应变为4%。在频率扫描测试中,储存模量和损失模量随频率增加,储存模量的中位数在10Pa至30Pa之间,损失模量的中位数从5Pa至14Pa之间。Burgers模型适当地近似了气管支气管粘液在恒定应力载荷下的粘弹性行为(R2为0.99),威布尔分布适用于预测样品在去除该应力后的恢复(R2为0.99)。六元Maxwell模型对应力松弛试验数据的近似显示出较大的拟合误差(R2为0.91)。结论:本研究详细描述了表征气管支气管粘液流变学的所有过程步骤,包括样品采集、微观结构可视化和流变学研究。在此基础上,我们提供了气管支气管粘液流变行为的数学模型。这些现在可以通过数值方法模拟呼吸系统中的粘液流动。
{"title":"Experimental studies and mathematical modeling of the viscoelastic rheology of tracheobronchial mucus from respiratory healthy patients.","authors":"Sandra Melina Tauwald,&nbsp;Johanna Michel,&nbsp;Marie Brandt,&nbsp;Veronika Vielsmeier,&nbsp;Christian Stemmer,&nbsp;Lars Krenkel","doi":"10.4081/mrm.2023.923","DOIUrl":"https://doi.org/10.4081/mrm.2023.923","url":null,"abstract":"<p><strong>Background: </strong>Tracheobronchial mucus plays a crucial role in pulmonary function by providing protection against inhaled pathogens. Due to its composition of water, mucins, and other biomolecules, it has a complex viscoelastic rheological behavior. This interplay of both viscous and elastic properties has not been fully described yet. In this study, we characterize the rheology of human mucus using oscillatory and transient tests. Based on the transient tests, we describe the material behavior of mucus under stress and strain loading by mathematical models.</p><p><strong>Methods: </strong>Mucus samples were collected from clinically used endotracheal tubes. For rheological characterization, oscillatory amplitude-sweep and frequency-sweep tests, and transient creep-recovery and stress-relaxation tests were performed. The results of the transient test were approximated using the Burgers model, the Weibull distribution, and the six-element Maxwell model. The three-dimensional microstructure of the tracheobronchial mucus was visualized using scanning electron microscope imaging.</p><p><strong>Results: </strong>Amplitude-sweep tests showed storage moduli ranging from 0.1 Pa to 10,000 Pa and a median critical strain of 4%. In frequency-sweep tests, storage and loss moduli increased with frequency, with the median of the storage modulus ranging from 10 Pa to 30 Pa, and the median of the loss modulus from 5 Pa to 14 Pa. The Burgers model approximates the viscoelastic behavior of tracheobronchial mucus during a constant load of stress appropriately (R<sup>2</sup> of 0.99), and the Weibull distribution is suitable to predict the recovery of the sample after the removal of this stress (R<sup>2</sup> of 0.99). The approximation of the stress-relaxation test data by a six-element Maxwell model shows a larger fit error (R<sup>2</sup> of 0.91).</p><p><strong>Conclusions: </strong>This study provides a detailed description of all process steps of characterizing the rheology of tracheobronchial mucus, including sample collection, microstructure visualization, and rheological investigation. Based on this characterization, we provide mathematical models of the rheological behavior of tracheobronchial mucus. These can now be used to simulate mucus flow in the respiratory system through numerical approaches.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"18 1","pages":"923"},"PeriodicalIF":2.3,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71428943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re-admission and quality of life among patients with chronic obstructive pulmonary disease after telemedicine video nursing consultation - a randomized study. 远程医疗视频护理咨询后慢性阻塞性肺病患者的再次入院和生活质量——一项随机研究。
IF 2 Q3 RESPIRATORY SYSTEM Pub Date : 2023-09-11 eCollection Date: 2023-01-17 DOI: 10.4081/mrm.2023.918
Safaa Saleh, Svein Skeie, Heidi Grundt

Background: Our previous study showed a reduced cumulative length of re-admission stays due to chronic obstructive pulmonary disease (COPD) exacerbations during one year after telemedicine video consultation (TVC). The current study evaluated the effects of TVC on the length of re-admission stays within 12 months follow up post-TVC compared to phone call follow up or COPD usual care in a randomized study. Our secondary aim was to assess the impact of TVC on the frequency of re-admissions within 12 months of follow up. Patient satisfaction, hospital anxiety and depression scale (HADS) and COPD assessment test (CAT) scores were also evaluated.

Methods: The study was a prospective randomized study of COPD patients who after hospital discharge for acute COPD exacerbations, were randomized to monitoring by TVC at home compared to phone call follow up for two weeks by a specialist nurse at the hospital or usual COPD care. Prospectively, we compared the cumulative durations and frequencies of hospital re-admissions due to COPD exacerbations within 12 months follow up after TVC, phone call follow up or usual COPD care.

Results: Among 173 COPD patients followed for 12 months, 99 were re-admitted. The median cumulative length of readmission stays per patient within 12 months post-TVC did not differ from those followed by phone calls or with usual COPD care. The number of patients re-admitted and the number of re-admissions due to COPD exacerbations were also equal in the three groups. Patient satisfaction was high among those followed by TVC and phone calls, and the HADS and CAT scores favorably declined from baseline to post-intervention in patients followed by TVC and phone calls.

Conclusions: The study could not demonstrate a beneficial effect of TVC on the cumulative length of re-admission stays or on the number of re-admissions within 12 months following an acute COPD hospital stay, as compared to those followed by phone calls or with usual COPD care. Patient satisfaction was high among those followed by TVC and phone calls, and the declines in HADS and CAT scores seem to be consequences of increased empowerment and competence for good self-care in COPD patients, remaining through the one-year observation period.

背景:我们之前的研究表明,在远程医疗视频会诊(TVC)后的一年内,由于慢性阻塞性肺病(COPD)的恶化,再次入院的累计住院时间缩短。在一项随机研究中,与电话随访或COPD常规护理相比,目前的研究评估了TVC对TVC后12个月内再次入院停留时间的影响。我们的次要目的是评估TVC对随访12个月内再次入院频率的影响。患者满意度、医院焦虑抑郁量表(HADS)和COPD评估测试(CAT)评分也进行了评估。方法:这项研究是一项前瞻性随机研究,研究对象是因急性COPD恶化出院后的COPD患者,他们被随机分配到家中接受TVC监测,与医院专科护士或常规COPD护理的电话随访两周进行比较。前瞻性地,我们比较了TVC、电话随访或常规COPD护理后12个月内因COPD恶化而再次入院的累计持续时间和频率。结果:173例COPD患者随访12个月,其中99例再次入院。TVC后12个月内每位患者再次入院的中位累计住院时间与电话或常规COPD护理后的中位累积住院时间没有差异。三组中因COPD恶化而再次入院的患者人数和再次入院的人数也相等。在接受TVC和电话治疗的患者中,患者满意度较高,在接受TVD和电话治疗患者中,HADS和CAT评分从基线到干预后都有所下降。结论:与电话或常规COPD护理相比,该研究无法证明TVC对急性COPD住院后12个月内的累计再入院时间或再入院次数有有益影响。在接受TVC和电话随访的患者中,患者满意度很高,HADS和CAT评分的下降似乎是COPD患者在一年的观察期内增强了自我护理能力的结果。
{"title":"Re-admission and quality of life among patients with chronic obstructive pulmonary disease after telemedicine video nursing consultation - a randomized study.","authors":"Safaa Saleh, Svein Skeie, Heidi Grundt","doi":"10.4081/mrm.2023.918","DOIUrl":"10.4081/mrm.2023.918","url":null,"abstract":"<p><strong>Background: </strong>Our previous study showed a reduced cumulative length of re-admission stays due to chronic obstructive pulmonary disease (COPD) exacerbations during one year after telemedicine video consultation (TVC). The current study evaluated the effects of TVC on the length of re-admission stays within 12 months follow up post-TVC compared to phone call follow up or COPD usual care in a randomized study. Our secondary aim was to assess the impact of TVC on the frequency of re-admissions within 12 months of follow up. Patient satisfaction, hospital anxiety and depression scale (HADS) and COPD assessment test (CAT) scores were also evaluated.</p><p><strong>Methods: </strong>The study was a prospective randomized study of COPD patients who after hospital discharge for acute COPD exacerbations, were randomized to monitoring by TVC at home compared to phone call follow up for two weeks by a specialist nurse at the hospital or usual COPD care. Prospectively, we compared the cumulative durations and frequencies of hospital re-admissions due to COPD exacerbations within 12 months follow up after TVC, phone call follow up or usual COPD care.</p><p><strong>Results: </strong>Among 173 COPD patients followed for 12 months, 99 were re-admitted. The median cumulative length of readmission stays per patient within 12 months post-TVC did not differ from those followed by phone calls or with usual COPD care. The number of patients re-admitted and the number of re-admissions due to COPD exacerbations were also equal in the three groups. Patient satisfaction was high among those followed by TVC and phone calls, and the HADS and CAT scores favorably declined from baseline to post-intervention in patients followed by TVC and phone calls.</p><p><strong>Conclusions: </strong>The study could not demonstrate a beneficial effect of TVC on the cumulative length of re-admission stays or on the number of re-admissions within 12 months following an acute COPD hospital stay, as compared to those followed by phone calls or with usual COPD care. Patient satisfaction was high among those followed by TVC and phone calls, and the declines in HADS and CAT scores seem to be consequences of increased empowerment and competence for good self-care in COPD patients, remaining through the one-year observation period.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"18 1","pages":"918"},"PeriodicalIF":2.0,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/fe/mrm-18-1-918.PMC10519187.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41169079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Multidisciplinary Respiratory Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1